Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Edwards

Showing results (151-160 of 158) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 158 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervixC F Verschraegen, T Levy, A P Kudelka, et al.
Environmental Health Perspectives|April 1, 1997
During development, 17alpha-estradiol is a potent estrogen and carcinogenR A Hajek, A D Robertson, D A Johnston, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Long-term results and pharmacokinetics of high-dose paclitaxel in patients with refractory epithelial ovarian carcinomaA. P. Kudelka, C. F. Verschraegen, Y. Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinomaA P Kudelka, D Tresukosol, C L Edwards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1996
Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinumJ J Kavanagh, A P Kudelka, C G de Leon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinomaR S Freedman, A P Kudelka, J J Kavanagh, et al.
Anti-Cancer Drugs|August 1, 1997
An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervixA P Kudelka, R Winn, C L Edwards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervixA P Kudelka, T Levy, C F Verschraegen, et al.
Pageof 16

Showing results (151-160 of 158) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervixC F Verschraegen, T Levy, A P Kudelka, et al.
Environmental Health Perspectives|April 1, 1997
During development, 17alpha-estradiol is a potent estrogen and carcinogenR A Hajek, A D Robertson, D A Johnston, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Long-term results and pharmacokinetics of high-dose paclitaxel in patients with refractory epithelial ovarian carcinomaA. P. Kudelka, C. F. Verschraegen, Y. Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinomaA P Kudelka, D Tresukosol, C L Edwards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1996
Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinumJ J Kavanagh, A P Kudelka, C G de Leon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinomaR S Freedman, A P Kudelka, J J Kavanagh, et al.
Anti-Cancer Drugs|August 1, 1997
An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervixA P Kudelka, R Winn, C L Edwards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervixA P Kudelka, T Levy, C F Verschraegen, et al.
Pageof 16